Join Michael Hochman, MD, MPH, for the second episode of Updates in Slow Medicine. This installment discusses results from a recent study that raises the possibility that a…
NEW YORK (Reuters Health) – The need for late target lesion revascularization (TLR) with sirolimus-eluting coronary stents is reduced when patients receive ongoing statin therapy after stent implantation,…
NEW YORK (Reuters Health) – In real-world contemporary clinical practice, the use of the XIENCE V everolimus-eluting coronary stent is associated with lower mortality and reduced stent thrombosis…
NEW YORK (Reuters Health) – During 3 years of follow-up in patients who underwent percutaneous coronary intervention for acute coronary syndrome (ACS), overall outcomes were significantly better in…
NEW YORK (Reuters Health) – For patients with non-ST-segment elevation acute coronary syndrome (nSTE-ACS), long-term outcomes are no different whether they undergo angiography, and revascularization if indicated, within…
NEW YORK (Reuters Health) – Data from the German drug-eluting stent (DES.DE) Registry provide no evidence of the “obesity paradox” in the setting of percutaneous coronary intervention (PCI)…
NEW YORK (Reuters Health) – Newer generation everolimus-eluting stents (EES) are significantly less likely to prompt very late stent thrombosis than are the first generation of drug-eluting stents…
NEW YORK (Reuters Health) – The everolimus-eluting stent and the sirolimus-eluting stent are equally safe and efficacious in patients with coronary artery disease, the SORT OUT IV Trial…
NEW YORK (Reuters Health) – Long-term clinical outcomes of percutaneous intervention of complex coronary bifurcation lesions are significantly better when the procedure is performed with adjunctive intravascular ultrasound…
NEW YORK (Reuters Health) – Intracoronary artery infusion of autologous stem cells after primary PCI or thrombolysis for acute myocardial infarction improves left ventricular ejection fraction and left…
NEW YORK (Reuters Health) – In patients with heart failure requiring cardiac resynchronization therapy and coexistent atrial fibrillation, AV nodal ablation (AVNA) reduces mortality and improves NYHA functional…
